hotspot -WSS

hotspot

author：explore 2025-09-30 08:52:12 - browse：4861

A screen at the New York Stock Exchange last November. Michael M. Santiago/Getty Images

Pfizer spent more than four hours Thursday laying out its oncology program to investors. But the company also spent some time talking about the effects of the Inflation Reduction Act on its pipeline.

The drug giant, which is facing investor dissatisfaction after a year in which its stock dropped 44%, said it would be focusing on drugs that are based on proteins, not small molecule pills as it has traditionally developed. (Pfizer’s current best-seller in oncology, Ibrance for breast cancer, is a small molecule pill.) It said the mix of small molecule drugs in its cancer portfolio will drop from 94% last year to 35% in 2030.

That matters because small molecules are more vulnerable to generic competition and the Medicare price negotiation introduced by the IRA. Suneet Varma, the commercial president of Pfizer’s oncology unit, said “this planned shift to biologics is expected to support the accelerated growth in both the top and bottom line,” referring to the revenue and profit lines of a balance sheet.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： What does generative AI mean for health care? We asked experts
Next article： Testing GLP

knowledge

WSS

Yancopoulos of Regeneron works to expand Dupixent success

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

NEJM study measures Covid brain fog, impact on IQ

Bring on the sabbaticals for nurses

Steward Health Care expansion into Malta flopped

Study fuels hope CAR

hotspot

hotspot

entertainment

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Steward Health Care expansion into Malta flopped

Anesthesiologist group: stop taking Ozempic before surgery

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Are embryos people? Reproductive medicine's future depends on the answer

Supreme Court strikes down use of affirmative action

Doctor of U.S. President Joe Biden says he is fit for duty

How one medical school became remarkably diverse

With Wegovy coverage, Medicare patients may face high costs

leisure time

Medical devices makers are asking for forgiveness, not permission

This gene therapy has record $4.25 million price. It's saved children.

CDC panel: People 65 and older should get a Covid spring booster shot

Readout LOUD podcast, live from the STAT Breakthrough Summit East

Pregnancy ages women, but effects reverse after delivery

Diabetes management: Digital health tools fall short, study says

leisure time

explore

knowledge

focus